Drug Type Biosimilar, Hormone |
Synonyms Admelog, insulin lispro biosimilar, Insulin lispro Sanofi + [2] |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date European Union (19 Jul 2017), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 1 | United States | 11 Dec 2017 | |
Diabetes Mellitus, Type 2 | United States | 11 Dec 2017 | |
Diabetes Mellitus | European Union | 19 Jul 2017 | |
Diabetes Mellitus | Iceland | 19 Jul 2017 | |
Diabetes Mellitus | Liechtenstein | 19 Jul 2017 | |
Diabetes Mellitus | Norway | 19 Jul 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes, Gestational | Phase 2 | United States | 01 Apr 2013 |
Phase 1 | 27 | SAR-Lis | udgozhdwkz(kytcleqczn) = yryzxwwoly dytrpgvyql (rhmyqzohfr ) View more | - | 01 May 2018 | ||
Ly-Lis | udgozhdwkz(kytcleqczn) = uifhqoavbr dytrpgvyql (rhmyqzohfr ) View more | ||||||
Phase 3 | 507 | Insulin glargine HOE901+SAR342434 (SAR342434) | zaxskzwnqb(cytxggkdvw) = jhimszpnll msubkgswdg (munthseiom, 0.051) View more | - | 18 Jan 2018 | ||
Insulin glargine HOE901+humalog (Humalog) | zaxskzwnqb(cytxggkdvw) = gqgcorpzyf msubkgswdg (munthseiom, 0.05) View more | ||||||
Phase 3 | 505 | (SAR342434) | itnthhjcfo(vhwrmcoyjz) = pxxooaiuzb eslrpepant (hrrbvrdrbe, 0.051) View more | - | 18 Jan 2018 | ||
(Humalog) | itnthhjcfo(vhwrmcoyjz) = bvzogjyfxa eslrpepant (hrrbvrdrbe, 0.051) View more | ||||||
Phase 3 | 507 | nywcpkqwhk(xevwcrviaw) = jtllzvsmzr pekvpsfast (czslpjinbv ) | Similar | 01 Sep 2017 | |||
nywcpkqwhk(xevwcrviaw) = qkrxjermcb pekvpsfast (czslpjinbv ) | |||||||
Phase 1 | 30 | uajrofrfgu(ihuyzaites) = similar for SAR342434 solution, US-approved insulin lispro solution, and EU-approved insulin lispro solution ajflrofbcf (bfaedaaahq ) View more | Positive | 16 Sep 2015 | |||
US-approved insulin lispro solution |